138 related articles for article (PubMed ID: 2392142)
1. Treating drug problems.
Gerstein DR; Lewin LS
N Engl J Med; 1990 Sep; 323(12):844-8. PubMed ID: 2392142
[No Abstract] [Full Text] [Related]
2. A structured, therapeutic approach to drug abuse.
Alonzi J; Faigel HC
Pediatrics; 1972 Nov; 50(5):754-9. PubMed ID: 5084188
[No Abstract] [Full Text] [Related]
3. A differential counselor role model for the treatment of drug addicts.
Cuskey WR; Premkumar T
Health Serv Rep; 1973; 88(7):663-8. PubMed ID: 4746235
[No Abstract] [Full Text] [Related]
4. Drug abuse programs: are hospitals too late and too square?
Philips DF
Hospitals; 1971 Jan; 45(2):55-60. PubMed ID: 5123315
[No Abstract] [Full Text] [Related]
5. Treatment facilities for drug-dependent patients. Some impressions of treatment programmes in the United States and Canada.
Jensen GR
Med J Aust; 1973 Apr; 1(16):808-12. PubMed ID: 4707801
[No Abstract] [Full Text] [Related]
6. The quality of treatment for drug abuse.
Glaser FB; Adler F; Moffett AD; Ball JC
Am J Psychiatry; 1974 May; 131(5):598-601. PubMed ID: 4819055
[No Abstract] [Full Text] [Related]
7. The effectiveness of drug treatment.
Gerstein DR
Res Publ Assoc Res Nerv Ment Dis; 1992; 70():253-82. PubMed ID: 1311121
[No Abstract] [Full Text] [Related]
8. Forecasting the cost of drug abuse treatment coverage in private health insurance.
McGuire TG; Shatkin BF
NIDA Res Monogr; 1991; 113():175-89. PubMed ID: 1762639
[No Abstract] [Full Text] [Related]
9. What's happening in hard-drug rehabilitation?
Walls RT; Gulkus SP
Rehabil Lit; 1973 Jan; 34(1):2-6. PubMed ID: 4683507
[No Abstract] [Full Text] [Related]
10. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
Zarkin GA; Dunlap LJ; Homsi G
Eval Rev; 2006 Apr; 30(2):119-38. PubMed ID: 16492995
[TBL] [Abstract][Full Text] [Related]
11. Treating the drug-dependent veteran.
Van Stone W; Zarcone V; Bale R; Engelsing T
Curr Psychiatr Ther; 1976; 16():215-22. PubMed ID: 991633
[No Abstract] [Full Text] [Related]
12. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
Goldschmidt PG
Inquiry; 1976 Mar; 13(1):29-47. PubMed ID: 130347
[No Abstract] [Full Text] [Related]
13. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
Woodward AM; Raskin IE; Blacklow B
Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
[TBL] [Abstract][Full Text] [Related]
14. Study tracks costs of treating employees' drug problems.
Kim H
Mod Healthc; 1991 Jan; 21(3):18. PubMed ID: 10170655
[No Abstract] [Full Text] [Related]
15. [When and how one can leave a methadone treatment program?].
Lauzon P
Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():94-5. PubMed ID: 7880041
[No Abstract] [Full Text] [Related]
16. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
17. The effect of alternative staff time data collection methods on drug treatment service cost estimates.
Zarkin GA; Dunlap LJ; Wedehase B; Cowell AJ
Eval Program Plann; 2008 Nov; 31(4):427-35. PubMed ID: 18640722
[TBL] [Abstract][Full Text] [Related]
18. Cost containment: a challenge to physicians.
Magee TM
Conn Med; 1987 Jul; 51(7):485. PubMed ID: 3665473
[No Abstract] [Full Text] [Related]
19. The methadone method.
Whyman JS; Woody GE; Patch VD
N Engl J Med; 1972 Mar; 286(13):728-9. PubMed ID: 5061064
[No Abstract] [Full Text] [Related]
20. The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.
Harwood HJ; Hubbard RL; Collins JJ; Rachal JV
NIDA Res Monogr; 1988; 86():209-35. PubMed ID: 3140032
[No Abstract] [Full Text] [Related]
[Next] [New Search]